FI962354A - Pitkävaikutteisia ruiskesuspensioita ja menetelmä niiden valmistamiseksi - Google Patents

Pitkävaikutteisia ruiskesuspensioita ja menetelmä niiden valmistamiseksi Download PDF

Info

Publication number
FI962354A
FI962354A FI962354A FI962354A FI962354A FI 962354 A FI962354 A FI 962354A FI 962354 A FI962354 A FI 962354A FI 962354 A FI962354 A FI 962354A FI 962354 A FI962354 A FI 962354A
Authority
FI
Finland
Prior art keywords
preparation
low
injection suspensions
lasting effect
intrinsic
Prior art date
Application number
FI962354A
Other languages
English (en)
Swedish (sv)
Other versions
FI116121B (fi
FI962354A0 (fi
Inventor
Juergen Engel
Karin Klokkers-Bethke
Thomas Reissmann
Peter Hilgard
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Publication of FI962354A0 publication Critical patent/FI962354A0/fi
Publication of FI962354A publication Critical patent/FI962354A/fi
Priority claimed from US08/661,017 external-priority patent/US5773032A/en
Application granted granted Critical
Publication of FI116121B publication Critical patent/FI116121B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A61K38/105—Bombesin; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI962354A 1993-12-09 1996-06-06 Menetelmä LHRH-analogin embonaattisuolakoostumuksen valmistamiseksi FI116121B (fi)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
DE4342092A DE4342092B4 (de) 1993-12-09 1993-12-09 Langwirkende Injektionssuspension und Verfahren zur Herstellung
DE4342092 1993-12-09
EP9403904 1994-11-25
PCT/EP1994/003904 WO1995015767A1 (en) 1993-12-09 1994-11-25 Long-acting injection suspensions and a process for their preparation
US08/661,017 US5773032A (en) 1993-12-09 1996-06-10 Long-acting injection suspensions and a process for their preparation
US66101796 1996-06-10

Publications (3)

Publication Number Publication Date
FI962354A0 FI962354A0 (fi) 1996-06-06
FI962354A true FI962354A (fi) 1996-06-06
FI116121B FI116121B (fi) 2005-09-30

Family

ID=25931926

Family Applications (1)

Application Number Title Priority Date Filing Date
FI962354A FI116121B (fi) 1993-12-09 1996-06-06 Menetelmä LHRH-analogin embonaattisuolakoostumuksen valmistamiseksi

Country Status (27)

Country Link
EP (1) EP0732934B1 (fi)
JP (1) JPH09509145A (fi)
CN (2) CN1248732C (fi)
AT (1) ATE310530T1 (fi)
AU (1) AU677748B2 (fi)
BR (1) BR9408272A (fi)
CZ (1) CZ291025B6 (fi)
DE (1) DE4342092B4 (fi)
DK (1) DK0732934T3 (fi)
EE (1) EE03224B1 (fi)
EG (1) EG20787A (fi)
ES (1) ES2251715T3 (fi)
FI (1) FI116121B (fi)
HK (1) HK1063746A1 (fi)
HR (1) HRP940978B1 (fi)
HU (1) HU217081B (fi)
IL (1) IL111928A (fi)
LV (1) LV11596B (fi)
NO (1) NO318984B1 (fi)
NZ (1) NZ277239A (fi)
PL (1) PL186929B1 (fi)
RO (1) RO119343B1 (fi)
RS (1) RS49511B (fi)
RU (1) RU2152222C1 (fi)
SK (2) SK284981B6 (fi)
WO (1) WO1995015767A1 (fi)
ZA (1) ZA949798B (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6828415B2 (en) * 1993-02-19 2004-12-07 Zentaris Gmbh Oligopeptide lyophilisate, their preparation and use
UA44722C2 (uk) * 1993-12-09 2002-03-15 Аста Медіка Акціенгезельшафт Лікарський засіб пролонгованої дії для зниження рівня тестостерону
AU5678398A (en) * 1997-01-29 1998-08-18 Takeda Chemical Industries Ltd. Sustained-release microspheres, their production and use
DE10040700A1 (de) * 2000-08-17 2002-02-28 Asta Medica Ag Salze von biologisch aktiven Peptiden, ihre Herstellung und Verwendung
AU2002221139A1 (en) * 2000-12-15 2002-06-24 Takeda Chemical Industries Ltd. Medicinal compositions of nonpeptidyl gonadotropin-releasing hormone agonist or antagonist, process for producing the same and use thereof
TWI332407B (en) 2001-06-29 2010-11-01 Takeda Chemical Industries Ltd Controlled release composition and method of producting the same
US7098305B2 (en) 2001-09-06 2006-08-29 Ardana Bioscience Limited Sustained release of microcrystalline peptide suspensions
EP1674082A1 (de) 2004-12-22 2006-06-28 Zentaris GmbH Verfahren zur Herstellung von sterilen Suspensionen oder Lyophilisaten schwerlöslicher basischer Peptidkomplexe, diese enthaltende pharmazeutische Formulierungen sowie ihre Verwendung als Arzneimittel
CN101563068B (zh) 2006-12-18 2013-03-20 武田药品工业株式会社 缓释组合物和其制备方法
RU2548753C2 (ru) 2009-11-16 2015-04-20 Ипсен Фарма С.А.С. Фармацевтические композиции лигандов рецепторов меланокортинов
CN102504018A (zh) * 2011-10-28 2012-06-20 沈阳药科大学 可持续释放的蜂毒肽帕莫酸盐及其制剂
WO2017167180A1 (zh) * 2016-03-29 2017-10-05 上海华汇拓医药科技有限公司 沃替西汀的帕莫酸盐及其晶型
CN108969478A (zh) * 2018-08-29 2018-12-11 江南大学 一种美金刚难溶盐缓释注射剂及其制备方法
CN110003195B (zh) * 2019-05-21 2020-05-26 湖北中医药大学 鲁拉西酮晶体及其制备方法和在注射给药系统中的应用
CN112569340A (zh) * 2020-12-31 2021-03-30 苏州素仕生物科技有限公司 一种无菌布舍瑞林注射液及其制备方法和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3852422A (en) * 1971-06-26 1974-12-03 Serono Ist Farm Long-active gonadotropins
NZ181036A (en) * 1975-06-12 1978-12-18 A Schally Luteinising hormone releasing hormone analogues and intermediates therefor
GB2209937B (en) * 1987-09-21 1991-07-03 Depiopharm S A Water insoluble polypeptides
FR2647677B1 (fr) * 1989-05-31 1991-09-27 Roussel Uclaf Nouvelles micro-proteines, procede de preparation et application a titre de medicaments de ces nouvelles micro-proteines
CH679207A5 (fi) * 1989-07-28 1992-01-15 Debiopharm Sa
CH683149A5 (fr) * 1991-07-22 1994-01-31 Debio Rech Pharma Sa Procédé pour la préparation de microsphères en matériau polymère biodégradable.

Also Published As

Publication number Publication date
PL186929B1 (pl) 2004-04-30
DE4342092B4 (de) 2007-01-11
EP0732934A1 (en) 1996-09-25
EG20787A (en) 2000-02-29
SK284980B6 (sk) 2006-03-02
CN1136916C (zh) 2004-02-04
WO1995015767A1 (en) 1995-06-15
ES2251715T3 (es) 2006-05-01
NO961877L (no) 1996-05-09
HRP940978B1 (en) 2006-08-31
CZ142096A3 (en) 1996-12-11
DE4342092A1 (de) 1995-06-14
DK0732934T3 (da) 2006-03-27
NZ277239A (en) 1997-03-24
RS49511B (sr) 2006-10-27
LV11596A (lv) 1996-12-20
HU9601584D0 (en) 1996-08-28
RO119343B1 (ro) 2004-08-30
JPH09509145A (ja) 1997-09-16
AU1219995A (en) 1995-06-27
FI116121B (fi) 2005-09-30
AU677748B2 (en) 1997-05-01
HU217081B (hu) 1999-11-29
IL111928A (en) 1999-11-30
CN1494919A (zh) 2004-05-12
NO961877D0 (no) 1996-05-09
NO318984B1 (no) 2005-05-30
CN1136779A (zh) 1996-11-27
SK284981B6 (sk) 2006-03-02
CN1248732C (zh) 2006-04-05
ZA949798B (en) 1995-08-18
FI962354A0 (fi) 1996-06-06
SK66796A3 (en) 1997-08-06
EE03224B1 (et) 1999-10-15
EP0732934B1 (en) 2005-11-23
RU2152222C1 (ru) 2000-07-10
HRP940978A2 (en) 1997-02-28
CZ291025B6 (cs) 2002-12-11
YU72194A (sh) 1997-03-07
IL111928A0 (en) 1995-03-15
PL314913A1 (en) 1996-09-30
BR9408272A (pt) 1996-12-17
ATE310530T1 (de) 2005-12-15
HK1063746A1 (en) 2005-01-14
HUT75712A (en) 1997-05-28
LV11596B (en) 1997-06-20

Similar Documents

Publication Publication Date Title
FI962354A (fi) Pitkävaikutteisia ruiskesuspensioita ja menetelmä niiden valmistamiseksi
BG101781A (en) Active substance-containing solid preparation
ES2084825T3 (es) Procedimiento de preparacion de poliamidas entrecruzadas.
FI971776A (fi) Yhdisteet ja koostumukset aktiivisten aineiden antamiseksi
GB8922026D0 (en) Novel anti-viral and cytotoxic agent
PL325825A1 (en) Microemulsion for use as a carrier for administering active compounds
WO1998017319A3 (en) Platelet substitutes and conjugation methods suitable for their preparation
CA2178592A1 (en) Long-acting injection suspensions and a process for their preparation
FI964253A (fi) Kollageenivalmiste vaikuttavien aineiden säädellyksi vapauttamiseksi
DE59504351D1 (de) Implantierbare formkörper zur verabreichung von wirkstoffen an pflanzen
DE59410132D1 (de) Humanes zirkulierendes cytokin cc-1
CA2273272A1 (en) Immediate release drug delivery forms
MY119896A (en) Long-acting injection suspensions and a process for their preparation.
TR199701463T1 (en) Sorbin asiti i�eren hidrojel.
MX9604539A (es) Aminoacidos modificados para la distribucion de farmaco.
NZ335720A (en) Harvester (typically for kumara) with blade, in front of conveyor, having differing degrees of inclination, and such blade for harvester
ITRM920760A0 (it) Derivati amminoacilici e oligopeptidici dell'ipoxantina b-sostituita dotati di attivita' immunostimolante e composizioni farmaceutiche che li contengono.

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 116121

Country of ref document: FI

MM Patent lapsed